Albuminuria
Albuminuria
Explore linked clinical trials. Standard reference: MESH:M000063022 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Family Investigation of Nephropathy and Diabetes (F.I.N.D.) | Albuminuria, Diabetes Complications, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, diabetes mellitus, diabetic kidney disease, endocrine system disorder, glucose metabolism disease, kidney disorder, metabolic disease, proteinuria, type 2 diabetes mellitus, urinary system disorder | Active, not recruiting | Not stated | 2026-10-08 | NCT00342927 | |
| Study on the Efficacy and Safety of Initial Combination of Finerenone and Semaglutide in Non-Diabetic Adult Patients With Obesity Complicated by Chronic Kidney Disease With Albuminuria | Albuminuria, Body Weight, Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, chronic renal failure syndrome, kidney disorder, kidney failure, nutritional disorder, obesity disorder, overnutrition, proteinuria, urinary system disorder | Not yet recruiting | Not applicable | 2026-09-30 | NCT07849348 | |
| Systemic Immune-Inflammation Index and Platelet Parameters in Diabetic Kidney Disease | Albuminuria, Diabetes Complications, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, diabetes mellitus, diabetic kidney disease, endocrine system disorder, glucose metabolism disease, kidney disorder, metabolic disease, proteinuria, type 2 diabetes mellitus, urinary system disorder | Not yet recruiting | Not stated | 2026-08-19 | NCT07773467 | |
| RAndomized EHR-based Prescribing to Improve Disease-modifying Therapies for Cardio-Kidney-Metabolic Care (RAPID-CKM) | Albuminuria, Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, chronic renal failure syndrome, diabetes mellitus, endocrine system disorder, glucose metabolism disease, kidney disorder, kidney failure, metabolic disease, proteinuria, type 2 diabetes mellitus, urinary system disorder | Not yet recruiting | Not applicable | 2026-07-20 | NCT07605390 | |
| Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes | Albuminuria, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, proteinuria, urinary system disorder | Recruiting | Phase 4 | 2026-06-30 | NCT05498116 | |
| Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney Disease | Albuminuria, Chronic Disease, Chronic Kidney Diseases, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, chronic renal failure syndrome, diabetes mellitus, endocrine system disorder, glucose metabolism disease, kidney disorder, kidney failure, metabolic disease, proteinuria, type 2 diabetes mellitus, urinary system disorder | Not yet recruiting | Phase 4 | 2026-06-25 | NCT07667517 | |
| Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin | Albuminuria, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, Male Urogenital Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, proteinuria, sickle cell disease, urinary system disorder | Recruiting | Phase 2 | 2026-05-19 | NCT07175051 | |
| Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria | Albuminuria, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hematuria, Hemorrhage, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, glomerulonephritis, kidney disorder, nephritis, proteinuria, urinary system disorder | Not yet recruiting | Not applicable | 2026-05-12 | NCT07431931 | |
| Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD) | Albuminuria, Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hyperkalemia, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, Water-Electrolyte Imbalance, chronic renal failure syndrome, diabetes mellitus, endocrine system disorder, glucose metabolism disease, kidney disorder, kidney failure, metabolic disease, proteinuria, type 2 diabetes mellitus, urinary system disorder | Not yet recruiting | Phase 4 | 2026-05-08 | NCT07547878 | |
| Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa | Albuminuria, Blood-Borne Infections, Body Weight, Chronic Disease, Chronic Kidney Diseases, Disease Attributes, Dyslipidemias, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, HIV infectious disease, Hemic and Lymphatic Diseases, Infections, Lipid Metabolism Disorders, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Signs and Symptoms, Thinness, Underweight, Urination Disorders, Urogenital Diseases, Urological Manifestations, anemia, cardiovascular disorder, chronic renal failure syndrome, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hematologic disorder, hypertensive disorder, immune system disorder, inborn error of immunity, infectious disease, kidney disorder, kidney failure, lentivirus infection, metabolic disease, nutritional disorder, obesity disorder, overnutrition, proteinuria, sexually transmitted disease, type 2 diabetes mellitus, urinary system disorder, uterine carcinosarcoma, vascular disorder, viral infectious disease, viral sexually transmitted disease | Recruiting | Not stated | 2026-04-29 | NCT05881447 | |
| Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Disease | Albuminuria, Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, chronic renal failure syndrome, kidney disorder, kidney failure, proteinuria, urinary system disorder | Recruiting | Phase 4 | 2026-04-27 | NCT07405216 | |
| FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors | Albuminuria, Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, chronic renal failure syndrome, kidney disorder, kidney failure, proteinuria, urinary system disorder | Enrolling by invitation | Phase 3 | 2026-04-14 | NCT07181135 | |
| The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study | Albuminuria, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, cardiovascular disorder, heart disorder, heart failure, proteinuria, urinary system disorder | Recruiting | Phase 2 | 2026-04-14 | NCT06059664 | |
| Rubix LS Diabetic Kidney Disease (DKD) Registry Study | Albuminuria, Chronic Disease, Diabetes Complications, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, chronic renal failure syndrome, diabetes mellitus, diabetic kidney disease, endocrine system disorder, glucose metabolism disease, kidney disorder, kidney failure, metabolic disease, proteinuria, type 2 diabetes mellitus, urinary system disorder | Active, not recruiting | Not stated | 2026-01-16 | NCT07348718 | |
| The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease | Albuminuria, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, acute kidney injury, kidney disorder, kidney failure, proteinuria, urinary system disorder | Recruiting | Phase 2 | 2026-01-02 | NCT06528405 | |
| Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors | Albuminuria, Chronic Disease, Chronic Kidney Diseases, Diabetes Complications, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, chronic renal failure syndrome, diabetes mellitus, diabetic kidney disease, endocrine system disorder, kidney disorder, kidney failure, proteinuria, urinary system disorder | Recruiting | Not stated | 2025-12-24 | NCT04916132 | |
| Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study | Albuminuria, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, proteinuria, urinary system disorder | Enrolling by invitation | Phase 4 | 2025-12-22 | NCT06954090 | |
| Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE) | Albuminuria, Body Weight, Cardiomegaly, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hypertrophy, Hypertrophy, Left Ventricular, Hyperuricemia, Left Ventricular Diastolic Dysfunction, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Pediatric Obesity, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, Ventricular Dysfunction, Ventricular Dysfunction, Left, autonomic nervous system disorder, cardiovascular disorder, heart disorder, hypertensive disorder, kidney disorder, nervous system disorder, nutritional disorder, obesity disorder, overnutrition, primary dysautonomia, proteinuria, urinary system disorder, vascular disorder | Recruiting | Not stated | 2025-12-11 | NCT04752293 | |
| Hypertension in Children and Young People at Risk of Autosomal Dominant Polycystic Kidney Disease | Abnormalities, Multiple, Albuminuria, Ciliopathies, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, autosomal dominant polycystic kidney disease, cardiovascular disorder, cystic kidney disease, hereditary disease, hypertensive disorder, kidney disorder, polycystic kidney disease, proteinuria, urinary system disorder, vascular disorder | Recruiting | Not stated | 2025-12-02 | NCT07260071 | |
| Algae Effects in Markers of Cardiovascular Risk and Gut Microbiome | Albuminuria, Arterial Occlusive Diseases, Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Infarction, Male Urogenital Diseases, Necrosis, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, arteriosclerosis disorder, atherosclerosis, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, chronic renal failure syndrome, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, ischemic disease, kidney disorder, kidney failure, metabolic disease, myocardial infarction, myocardial ischemia, nervous system disorder, peripheral arterial disease, peripheral vascular disease, proteinuria, stroke disorder, urinary system disorder, vascular disorder | Recruiting | Not applicable | 2025-09-15 | NCT07173062 | |
| Effect Camostat for Kidney Protection in Chronic Kidney Disease | Albuminuria, Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, chronic renal failure syndrome, kidney disorder, kidney failure, proteinuria, urinary system disorder | Recruiting | Phase 2 | 2025-01-27 | NCT06794593 | |
| Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia | Albuminuria, Diabetes Complications, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hypoxia, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, Urination Disorders, Urogenital Diseases, Urological Manifestations, autoimmune disease, diabetes mellitus, diabetic kidney disease, endocrine system disorder, glucose metabolism disease, immune system disorder, kidney disorder, metabolic disease, proteinuria, type 1 diabetes mellitus, urinary system disorder | Not yet recruiting | Phase 2 | 2025-01-27 | NCT06147232 |